AMINOCAPROIC ACID
AMINOCAPROIC ACID · HYPERFIBRINOLYSIS-INDUCED HEMORRHAGE ·+1
BRYANT RANCH PR
Drug class
Aminocaproic Acid
Aminocaproic acid is a specific active drug ingredient rather than a formal therapeutic class; clinically, it is categorized within the antifibrinolytic class of hemostatic agents. Read more about Aminocaproic Acid
19 drugs in this class 18 manufacturers
Drugs in Aminocaproic Acid
Filter & compare in the drug finder →
Opens the drug finder with Aminocaproic Acid preselected. Add indication or manufacturer filters there.
Aminocaproic acid is a specific active drug ingredient rather than a formal therapeutic class; clinically, it is categorized within the antifibrinolytic class of hemostatic agents.
It functions as a synthetic lysine analogue that competitively binds to the lysine-binding sites on plasminogen, thereby inhibiting plasminogen activation and preventing fibrin degradation to stabilize formed blood clots.
Aminocaproic acid is primarily utilized to manage and prevent acute or excessive hemorrhage in clinical settings where hyperfibrinolysis contributes to bleeding, such as during cardiac surgery, dental procedures in patients with coagulopathies, and severe trauma.
-
fda.gov
Aminocaproic acid is a specific active drug ingredient rather than a formal therapeutic class; clinically, it is categorized within the antifibrinolytic class of hemostatic agents It functions as a synthetic lysine analogue that competitively binds to the lysine-binding sites on plasminogen, thereby inhibiting plasminogen activation and preventing fibrin degradation to stabilize formed blood clots
-
fda.gov
Aminocaproic acid is a specific active drug ingredient rather than a formal therapeutic class; clinically, it is categorized within the antifibrinolytic class of hemostatic agents
-
nih.gov
Aminocaproic acid is a specific active drug ingredient rather than a formal therapeutic class; clinically, it is categorized within the antifibrinolytic class of hemostatic agents
-
fda.gov
It functions as a synthetic lysine analogue that competitively binds to the lysine-binding sites on plasminogen, thereby inhibiting plasminogen activation and preventing fibrin degradation to stabilize formed blood clots
-
fda.gov
It functions as a synthetic lysine analogue that competitively binds to the lysine-binding sites on plasminogen, thereby inhibiting plasminogen activation and preventing fibrin degradation to stabilize formed blood clots Aminocaproic acid is primarily utilized to manage and prevent acute or excessive hemorrhage in clinical settings where hyperfibrinolysis contributes to bleeding, such as during cardiac surgery, dental procedures in patients with coagulopathies, and severe trauma
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.